Management of Tet Spells After Open-Heart Repair: Drug to Avoid
In the management of tet spells (hypercyanotic spells) after open-heart repair of tetralogy of Fallot, drugs that decrease systemic vascular resistance or increase right ventricular outflow tract obstruction should be avoided, though the provided evidence does not explicitly identify a specific contraindicated medication in the post-operative setting.
Understanding the Pathophysiology
The key to managing tet spells lies in understanding the underlying mechanism:
- Tet spells result from dynamic infundibular spasm causing increased right ventricular outflow tract (RVOT) obstruction
- This leads to increased right-to-left shunting and worsening cyanosis
- The goal is to increase systemic vascular resistance (SVR) and decrease RVOT obstruction
Evidence-Based Management Approach
For Infundibular Spasm (Pre-operative Tet Spells)
The guideline evidence 1 specifically addresses management of hypercyanotic spells in unrepaired tetralogy of Fallot, recommending ketamine for infundibular spasm at doses of:
- IV: 1-2 mg/kg, titrated to effect
- IM: 4-5 mg/kg (onset within ~5 minutes)
Important caveat: Ketamine should be avoided in patients with increased intracranial pressure or increased intraocular pressure 1.
Drugs to Avoid in Tet Spell Management
Based on physiologic principles and the evidence provided:
Drugs that decrease SVR should be avoided, as they worsen the right-to-left shunt by:
- Decreasing systemic resistance
- Increasing the pressure gradient favoring shunt flow from right to left
- Worsening cyanosis
This would include:
- Vasodilators (nitroprusside, nitroglycerin, hydralazine)
- Haloperidol - The guideline 1 warns that haloperidol can cause hypotension and dystonic reactions, making it inappropriate for tet spell management
Beta-agonists should also be avoided as they can:
- Increase heart rate, reducing diastolic filling time
- Potentially worsen dynamic RVOT obstruction
- Increase myocardial oxygen demand
Post-Operative Context
The evidence focuses primarily on adults with repaired tetralogy of Fallot 2, 3, 2, 3, 2, where the main concerns are:
- Residual pulmonary regurgitation
- RV dilation and dysfunction
- Arrhythmias
- Residual RVOT obstruction
True tet spells are uncommon after complete repair unless there is significant residual RVOT obstruction. The post-operative management focuses on:
- Monitoring for residual lesions
- Managing pulmonary regurgitation
- Preventing arrhythmias
Beta-Blocker Considerations
- Beta-blockers (particularly propranolol) are used prophylactically in unrepaired TOF to prevent tet spells
- Peak RVOT gradient is a poor predictor of hypercyanotic spells 5
- After complete repair, beta-blocker use is associated with longer hospital stays but no mortality benefit 4
However, in the acute management of a tet spell, beta-blockers can be beneficial by:
- Reducing heart rate
- Decreasing dynamic RVOT obstruction
- Reducing myocardial oxygen consumption
Clinical Algorithm for Post-Operative Cyanosis
If cyanosis occurs after TOF repair, systematically evaluate for:
- Residual right-to-left shunt through PFO or ASD 2
- Residual RVOT obstruction causing inadequate forward flow
- Pulmonary complications (atelectasis, pneumothorax, pulmonary edema)
- Low cardiac output state
Key Pitfalls to Avoid
- Do not use drugs that decrease SVR in the setting of suspected tet spell physiology
- Do not assume all post-operative cyanosis is a tet spell - evaluate for anatomic residual lesions 2
- Avoid haloperidol for agitation in these patients due to hypotension risk 1
- Do not rely solely on RVOT gradient to predict spell risk 5
The most critical principle is maintaining or increasing SVR while decreasing RVOT obstruction and heart rate - any medication working against these goals should be avoided.